Details

Autor(en) / Beteiligte

• Hara, Shintaro
• Mukae, Hiroshi
• Sakamoto, Noriho
• Ishimoto, Hiroshi
• Amenomori, Misato
• Fujita, Hanako
• Ishimatsu, Yuji
• Yanagihara, Katsunori
• Kohno, Shigeru

Titel

Plectasin has antibacterial activity and no affect on cell viability or IL-8 production

Ist Teil von

• Biochemical and biophysical research communications, 2008-10, Vol.374 (4), p.709-713

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2008

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Animals and plants express endogenous peptide antibiotics called defensins. Defensins show broad-spectrum antimicrobial activity, even against bacteria that have resistance to conventional antibiotics, which has made them viable candidates for new antibiotics. However, human defensins have failed to reach the market because of their cytotoxic effects and non-antimicrobial bioactivities. Plectasin is a defensin that has shown promise but has not had its potentially negative effects clarified. To address this issue, we examined plectasin’s cytotoxicity in human cells using an AlamarBlue reduction assay, its interleukin (IL)-8-inducing capacity using real-time PCR and ELISA, and measured its MIC against bacteria. We confirmed that plectasin has specific antibacterial activity against Streptococcus pneumoniae. Plectasin showed no cytotoxicity to A549 cells, normal human bronchial epithelial cells, or lung fibroblasts, and it did not induce IL-8 transcription or production in A549 cells. Our results suggest that plectasin could be an inoffensive alternative antibiotic for clinical application.